#news #biotech Synairgen’s inhaled interferon for COVID-19 enhances short harmless version of virus entry point: study

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Synairgen’s inhaled interferon for COVID-19 enhances short harmless version of virus entry point: study .Synairgen’s inhaled interferon for COVID-19 enhances short harmless version of virus entry point: study
arlene.weintraub
Mon, 01/11/2021 – 08:43

from FierceBiotech: Biotech https://ift.tt/3bBG2YG